JPS62909B2 - - Google Patents

Info

Publication number
JPS62909B2
JPS62909B2 JP4683278A JP4683278A JPS62909B2 JP S62909 B2 JPS62909 B2 JP S62909B2 JP 4683278 A JP4683278 A JP 4683278A JP 4683278 A JP4683278 A JP 4683278A JP S62909 B2 JPS62909 B2 JP S62909B2
Authority
JP
Japan
Prior art keywords
group
epoxysuccinic acid
ester
epoxysuccinic
yield
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4683278A
Other languages
Japanese (ja)
Other versions
JPS54141737A (en
Inventor
Kazunori Hanada
Shigeo Morimoto
Masaharu Tamai
Sadafumi Oomura
Jiro Sawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP4683278A priority Critical patent/JPS54141737A/en
Publication of JPS54141737A publication Critical patent/JPS54141737A/en
Publication of JPS62909B2 publication Critical patent/JPS62909B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はエポキシコハク酸ジエステル化合物に
関し、更に詳しくはチオール基がその活性の発現
に関与する蛋白分解酵素の活性を阻害するエポキ
シコハク酸ジエステル化合物に関するものであ
る。 本発明者らは、種々研究の結果、トランスエポ
キシコハク酸ジエステル化合物がチオール基がそ
の活性の発現に関与する蛋白分解酵素の活性を強
力に阻害し、しかも極めて低毒であることを見出
して本発明を完成した。 本発明を以下詳細に説明する。 本発明の目的化合物は、一般式 (式中、Rは、「ハロゲン原子、メチル基、メ
トキシ基及びトリフルオロメチル基」から選ばれ
る1〜3個の置換基を有するベンジル基、ピペロ
ニル基、1―ナフチルメチル基、「ハロゲン原子
およびメチル基」から選ばれる1〜2個の置換基
を有する1―ナフチルメチル基、3―フエニル―
2―プロペニル基、フルフリル基、2―テニル基
またはテトラヒドロフルフリル基を示す。)で表
わされるエポキシコハク酸ジエステル化合物であ
る。ここでハロゲン原子とは、フツ素、塩素、臭
素、ヨウ素である。また、ベンジル基または1―
ナフチルメチル基の置換基が2個以上ある場合、
それらは同一であつても相異なつてもよい。 一般式()で表わされる化合物〔以下化合物
()と略称する。〕は次の方法で製造することが
できる。即ち、エポキシコハク酸と 一般式 R―OH () (式中、Rは前記と同義である。)で表わされ
るアルコールを常法により硫酸等の酸性触媒存在
下に反応させるか、或いはエポキシコハク酸を五
塩化リン、オキザリルクロリドまたはチオニルク
ロリド等のハロゲン化剤で処理して得られるエポ
キシコハク酸ジハライドと当該アルコール()
を反応させエポキシコハク酸をエステル化する。
得られた反応液の溶媒を留去後、固化するものは
n―ヘキサン、n―ヘキサン―アセトンまたはn
―ヘキサン―エチルエーテル等の適当な溶媒系を
用い再結晶化し、油状のものは減圧分別蒸留によ
るかまたはシリカゲル等を担体としメタノール、
酢酸エチル、クロロホルム、ベンゼン等或いはそ
れらの適当な混合液を展開溶媒として用いるカラ
ムクロマトグラフイーで分離精製することにより
化合物()を得ることができる。尚、本明細書
における化合物()は全てトランス体である。 本発明の目的物である化合物()はチオール
基がその活性の発現に関与すると考えられている
パパイン、フイシン、ブロメリン、ブロメライン
及びカテプシンB等の蛋白分解酵素の活性を強力
に阻害し、しかもその毒性が極めて低い。化合物
()がこれらの酵素の活性を強力に阻害するこ
とを明らかにするため、パパインを用いた試験例
を次に示す。 試験例 20ミリモル濃度のエチレンジアミン四酢酸二ナ
トリウム溶液で40ミリモル濃度になるように調整
したシステイン溶液(PH6.8)0.25mlと化合物
()の10%ジメチルスルホキシド溶液0.25mlと
をパパイン水溶液(80μg/ml、シグマ社製、2
回結晶標品)0.5mlに加え、40℃にて15分間加温
した後基質として40℃に予温した1%ミルクカゼ
イン溶液〔33ミリモル濃度リン酸緩衝液(PH
6.8)〕5mlを加え、更に40℃にて10分間加温して
反応せしめた後、440ミリモル濃度のトリクロル
酢酸溶液5mlを加えて反応を停止せしめた。過
後、その液の280nmにおける吸光度Aを測定
し、同時に対照として化合物()の代わりに10
%ジメチルスルホキシド溶液を用いて吸光度Bを
測定し、活性阻害率をB−A/B×100より算出した。 この方法により50%の活性阻害を示す化合物の量
をID50とし第1表に示した。
The present invention relates to an epoxysuccinic acid diester compound, and more particularly to an epoxysuccinic acid diester compound whose thiol group inhibits the activity of a protease involved in the expression of the activity. As a result of various studies, the present inventors discovered that the thiol group of a trans-epoxysuccinic acid diester compound strongly inhibits the activity of proteases involved in the expression of its activity, and that it has extremely low toxicity. Completed the invention. The present invention will be explained in detail below. The object compound of the present invention has the general formula (In the formula, R is a benzyl group having 1 to 3 substituents selected from "halogen atom, methyl group, methoxy group and trifluoromethyl group", piperonyl group, 1-naphthylmethyl group, "halogen atom and 1-naphthylmethyl group, 3-phenyl group having 1 to 2 substituents selected from ``methyl group''
It represents a 2-propenyl group, a furfuryl group, a 2-tenyl group, or a tetrahydrofurfuryl group. ) is an epoxysuccinic acid diester compound represented by Here, the halogen atoms are fluorine, chlorine, bromine, and iodine. Also, benzyl group or 1-
When there are two or more substituents of the naphthylmethyl group,
They may be the same or different. A compound represented by the general formula () [hereinafter abbreviated as compound ()]. ] can be produced by the following method. That is, epoxysuccinic acid and an alcohol represented by the general formula R-OH () (wherein R has the same meaning as above) are reacted by a conventional method in the presence of an acidic catalyst such as sulfuric acid, or epoxysuccinic acid Epoxysuccinic acid dihalide obtained by treating with a halogenating agent such as phosphorus pentachloride, oxalyl chloride or thionyl chloride and the alcohol ()
to esterify epoxysuccinic acid.
After distilling off the solvent of the obtained reaction solution, the solidified substance is n-hexane, n-hexane-acetone, or n-hexane.
Recrystallize using a suitable solvent system such as -hexane-ethyl ether, and prepare the oil by fractional distillation under reduced pressure or by using silica gel as a carrier and methanol,
Compound () can be obtained by separation and purification by column chromatography using ethyl acetate, chloroform, benzene, etc., or an appropriate mixture thereof as a developing solvent. In addition, all compounds () in this specification are trans isomers. The compound (), which is the object of the present invention, strongly inhibits the activity of proteolytic enzymes such as papain, huicin, bromelain, bromelain, and cathepsin B, whose thiol group is thought to be involved in the expression of their activity, and furthermore, Extremely low toxicity. In order to demonstrate that compound () strongly inhibits the activity of these enzymes, a test example using papain is shown below. Test example 0.25 ml of a cysteine solution (PH6.8) adjusted to a 40 mmol concentration with a 20 mmol disodium ethylenediaminetetraacetic acid solution and 0.25 ml of a 10% dimethyl sulfoxide solution of compound () were mixed with an aqueous papain solution (80 μg/ ml, manufactured by Sigma, 2
Add to 0.5 ml of 1% milk casein solution [33 mmol concentration phosphate buffer (PH
6.8)] was added, and the mixture was further heated at 40°C for 10 minutes to react, and then 5 ml of a 440 mmol trichloroacetic acid solution was added to stop the reaction. After that, the absorbance A of the solution at 280 nm was measured, and at the same time, as a control, 10
Absorbance B was measured using a % dimethyl sulfoxide solution, and the activity inhibition rate was calculated from B-A/B×100. The amount of the compound showing 50% inhibition of activity by this method was defined as ID 50 and shown in Table 1.

【表】【table】

【表】 化合物()はトリプシンで代表されるセリン
蛋白分解酵素及びペプシンで代表される酸性蛋白
分解酵素のカゼイン分解活性を阻害しない。即
ち、化合物()はチオール基がその活性に関与
する蛋白分解酵素の活性のみを特異的に阻害する
だけで、その他の活性は全く阻害しない。 次に実施例を挙げて本発明を説明する。 実施例 1 p―ブロモベンジルアルコール3.74gとピリジ
ン1.58gをベンゼン50mlに溶解させた溶液にエポ
キシコハク酸ジクロリド1.68gをベンゼン10mlに
溶かした溶液を氷冷撹拌下滴下し、30分間撹拌後
生じたピリジン塩酸塩を去し、ベンゼン層を水
洗し、無水硫酸ナトリウムで乾燥後ベンゼンを留
去し、残渣をn―ヘキサン―アセトンより再結晶
して無色針状のエポキシコハク酸ジ―p―ブロム
ベンジルエステル3.43gを得た。 mp 124〜125℃収率73% 実施例 2 実施例1と同様にして、p―クロロベンジルア
ルコール2.84gとエポキシコハク酸ジクロリド
1.68gより無色針状のエポキシコハク酸ジ―p―
クロロベンジルエステル2.9gを得た。 mp 117℃ 収率76% 実施例 3 実施例1と同様にして、p―ヨードベンジルア
ルコール4.68gとエポキシコハク酸ジクロリド
1.68gより無色燐片状のエポキシコハク酸ジ―p
―ヨードベンジルエステル3.6gを得た。 収率64% mp 137〜139℃ 実施例 4 実施例1と同様にして、o―ヨードベンジルア
ルコール4.68gとエポキシコハク酸ジクロリド
1.68gより無色針状のエポキシコハク酸ジ―o―
ヨードベンジルエステル3.8gを得た。 収率67% mp 111〜112℃ 実施例 5 実施例1と同様にして、m―フルオロベンジル
アルコール2.52gとエポキシコハク酸ジクロリド
1.68gより無色針状のエポキシコハク酸ジ―m―
フルオロベンジルエステル2.5gを得た。 収率72% mp 37〜38℃ 実施例 6 実施例1と同様にして、p―メチルベンジルア
ルコール2.44gとエポキシコハク酸ジクロリド
1.68gより無色針状のエポキシコハク酸ジ―p―
メチルベンジルエステル2.8gを得た。 収率82% mp 77℃ 実施例 7 実施例1と同様にして、p―メトキシベンジル
アルコール2.76gとエポキシコハク酸ジクロリド
1.68gより無色燐片状のエポキシコハク酸ジ―p
―メトキシベンジルエステル2.9gを得た。 収率78% mp 82〜84℃ 実施例 8 実施例1と同様にして、ピペロニルアルコール
3.04gとエポキシコハク酸ジクロリド1.68gより
無色粉末状のエポキシコハク酸ジピペロニルエス
テル3.1gを得た。 収率78% mp 129〜132℃ 実施例 9 実施例1と同様にして、2,4―ジクロルベン
ジルアルコール3.52gとエポキシコハク酸ジクロ
リド1.68gより無色針状のエポキシコハク酸ジ―
2,4―ジクロロベンジルエステル3.2gを得
た。 収率71% mp 60℃ 実施例 10 実施例1と同様にして、シンナミルアルコール
2.68gとエポキシコハク酸ジクロリド1.68gより
無色針状のエポキシコハク酸ジシンナミルエステ
ル2.6gを得た。収率71% mp 165℃ 実施例 11 実施例1と同様にして、1―ナフチルメタノー
ル3.16gとエポキシコハク酸ジクロリド1.68gよ
り無色針状のエポキシコハク酸ジ―1―ナフチル
メチルエステル2.9gを得た。 収率70% mp 105〜107℃ 実施例1と同様にして、該当するアルコール及
びエポキシコハク酸ジクロリドを用いて、以下に
示すエポキシコハク酸ジエステルを得た。 エポキシコハク酸ジ―m―クロルベンジルエス
テル エポキシコハク酸ジ―o―クロルベンジルエス
テル エポキシコハク酸ジ―3―クロル―4―ブロム
ベンジルエステル エポキシコハク酸ジ―2,5―ジクロルベンジ
ルエステル エポキシコハク酸ジ―2―ブロム―4―ヨード
ベンジルエステル エポキシコハク酸ジ―2―ブロム―3―メチル
ベンジルエステル エポキシコハク酸ジ―1―(5′―ブロム)ナフ
チルメチルエステル エポキシコハク酸ジ―1―(2′―クロル)ナフ
チルメチルエステル エポキシコハク酸ジ―1―(4′,5′―ジメチ
ル)ナフチルメチルエステル 実施例 12 テトラヒドロフルフリルアルコール2.04gとピ
リジン1.58gをベンゼン50mlに溶解した溶液に、
エポキシコハク酸ジクロリド1.68gをベンゼン10
mlに溶解した液を、氷冷撹拌下滴下し30分間撹拌
後、生じたピリジン塩酸塩を去しベンゼン層を
水洗し無水硫酸ナトリウムで乾燥後ベンゼンを留
去する。残渣を減圧分別蒸留し無色油状のエポキ
シコハク酸ジテトラヒドロフルフリルエステル
2.4gを得た。 収率80% bp 221〜224℃(6mmHg) 実施例 13 フルフリルアルコール1.96gとピリジン1.58g
をベンゼン50mlに溶解しした溶液に、エポキシコ
ハク酸ジクロリド1.68gをベンゼン10mlに溶解し
た溶液を、氷冷撹拌下滴下し30分間撹拌後、生じ
たピリジン塩酸塩を去しベンゼン層を水洗し、
無水硫酸ナトリウムで乾燥後ベンゼンを留去す
る。残渣をn―ヘキサン―アセトン(10:1)を
展開溶媒としてシリカカラムクロマトグラフイー
にて精製し無色油状のエポキシコハク酸ジフルフ
リルエステル2.1gを得た。収率72% MS m/e:292(M+) IR νneat naxcm-1:1750,1185(エステル)91
8
(エポキシ) NMR(CDCl3)δ:3.65(2H,s,
[Table] Compound () does not inhibit the caseinolytic activity of serine proteases typified by trypsin and acidic proteases typified by pepsin. That is, compound () specifically inhibits only the activity of the protease in which the thiol group is involved, and does not inhibit any other activities. Next, the present invention will be explained with reference to Examples. Example 1 A solution of 1.68 g of epoxysuccinic acid dichloride dissolved in 10 ml of benzene was added dropwise to a solution of 3.74 g of p-bromobenzyl alcohol and 1.58 g of pyridine dissolved in 50 ml of benzene under ice-cooling and stirring, and after stirring for 30 minutes, a solution was formed. Pyridine hydrochloride was removed, the benzene layer was washed with water, and after drying over anhydrous sodium sulfate, the benzene was distilled off, and the residue was recrystallized from n-hexane-acetone to produce colorless needle-shaped di-p-bromobenzyl epoxysuccinate. 3.43 g of ester was obtained. mp 124-125℃ Yield 73% Example 2 In the same manner as in Example 1, 2.84 g of p-chlorobenzyl alcohol and epoxysuccinic acid dichloride were added.
Colorless acicular epoxysuccinic acid di-p- from 1.68g
2.9 g of chlorobenzyl ester was obtained. mp 117°C Yield 76% Example 3 In the same manner as in Example 1, 4.68 g of p-iodobenzyl alcohol and epoxysuccinic dichloride were added.
Colorless scaly epoxysuccinic acid di-p from 1.68g
-3.6g of iodobenzyl ester was obtained. Yield 64% mp 137-139°C Example 4 In the same manner as in Example 1, 4.68 g of o-iodobenzyl alcohol and epoxysuccinic acid dichloride were added.
Colorless acicular epoxysuccinic acid di-o- from 1.68g
3.8 g of iodobenzyl ester was obtained. Yield 67% mp 111-112°C Example 5 In the same manner as in Example 1, 2.52 g of m-fluorobenzyl alcohol and epoxysuccinic acid dichloride were added.
Colorless acicular epoxysuccinic acid di-m- from 1.68g
2.5 g of fluorobenzyl ester was obtained. Yield 72% mp 37-38°C Example 6 In the same manner as in Example 1, 2.44 g of p-methylbenzyl alcohol and epoxysuccinic dichloride were added.
Colorless acicular epoxysuccinic acid di-p- from 1.68g
2.8 g of methylbenzyl ester was obtained. Yield 82% mp 77°C Example 7 In the same manner as in Example 1, 2.76 g of p-methoxybenzyl alcohol and epoxysuccinic acid dichloride were added.
Colorless scaly epoxysuccinic acid di-p from 1.68g
-2.9 g of methoxybenzyl ester was obtained. Yield 78% mp 82-84℃ Example 8 Piperonyl alcohol was prepared in the same manner as in Example 1.
From 3.04 g and 1.68 g of epoxysuccinic acid dichloride, 3.1 g of epoxysuccinic acid dipiperonyl ester in the form of a colorless powder was obtained. Yield 78% mp 129-132°C Example 9 In the same manner as in Example 1, colorless acicular epoxysuccinic acid di-
3.2 g of 2,4-dichlorobenzyl ester was obtained. Yield 71% mp 60℃ Example 10 In the same manner as in Example 1, cinnamyl alcohol
2.6 g of colorless acicular epoxy succinic acid disinnamyl ester was obtained from 2.68 g of epoxy succinic acid dichloride. Yield 71% mp 165°C Example 11 In the same manner as in Example 1, 2.9 g of colorless needle-shaped epoxysuccinic acid di-1-naphthyl methyl ester was obtained from 3.16 g of 1-naphthylmethanol and 1.68 g of epoxysuccinic acid dichloride. Ta. Yield 70% mp 105-107°C In the same manner as in Example 1, the following epoxysuccinic acid diester was obtained using the corresponding alcohol and epoxysuccinic acid dichloride. Epoxysuccinic acid di-m-chlorobenzyl ester Epoxysuccinic acid di-o-chlorobenzyl ester Epoxysuccinic acid di-3-chloro-4-brombenzyl ester Epoxysuccinic acid di-2,5-dichlorobenzyl ester Epoxysuccinic acid di-2,5-dichlorobenzyl ester Di-2-bromo-4-iodobenzyl ester Epoxysuccinic acid di-2-bromo-3-methylbenzyl ester Epoxysuccinic acid di-1-(5'-bromo)naphthylmethyl ester Epoxysuccinic acid di-1-(2) '-Chlor) naphthyl methyl ester Epoxysuccinic acid di-1-(4',5'-dimethyl) naphthyl methyl ester Example 12 In a solution of 2.04 g of tetrahydrofurfuryl alcohol and 1.58 g of pyridine dissolved in 50 ml of benzene,
1.68g of epoxysuccinic acid dichloride and 10% of benzene
ml of the solution was added dropwise under ice-cooling and stirring for 30 minutes. After stirring for 30 minutes, the resulting pyridine hydrochloride was removed, the benzene layer was washed with water, dried over anhydrous sodium sulfate, and the benzene was distilled off. The residue was fractionally distilled under reduced pressure to obtain colorless oily epoxysuccinic acid ditetrahydrofurfuryl ester.
2.4g was obtained. Yield 80% bp 221-224℃ (6mmHg) Example 13 Furfuryl alcohol 1.96g and pyridine 1.58g
A solution of 1.68 g of epoxysuccinic acid dichloride dissolved in 10 ml of benzene was added dropwise to a solution of 1.68 g of epoxysuccinic acid dichloride dissolved in 50 ml of benzene under ice-cooling and stirring. After stirring for 30 minutes, the formed pyridine hydrochloride was removed and the benzene layer was washed with water.
After drying with anhydrous sodium sulfate, benzene is distilled off. The residue was purified by silica column chromatography using n-hexane-acetone (10:1) as a developing solvent to obtain 2.1 g of epoxysuccinic acid difurfuryl ester as a colorless oil. Yield 72% MS m/e: 292 (M + ) IR ν neat nax cm -1 : 1750, 1185 (ester) 91
8
(Epoxy) NMR (CDCl 3 ) δ: 3.65 (2H, s,

【式】),5.60(4H,s,2×―o―CH2 ―),6.25〜6.45(4H,m,
[Formula]), 5.60 (4H, s, 2×-o-CH 2 -), 6.25-6.45 (4H, m,

【式】),7.30〜7.43(2H,m,[Formula]), 7.30-7.43 (2H, m,

【式】) 実施例 14 実施例13と同様にして、2―チオフエンメタノ
ール2.28gとエポキシコハク酸ジクロリド1.68g
より淡黄色油状のエポキシコハク酸ジテニルエス
テル2.5gを得た。収率77% MS m/e:324(M+) IR νneat naxcm-1:1750,1185(エステル),
890
(エポキシ) NMR(CDCl3)δ:3.75(2H,s,
[Formula]) Example 14 In the same manner as in Example 13, 2.28 g of 2-thiophene methanol and 1.68 g of epoxysuccinic acid dichloride were added.
2.5 g of epoxysuccinic acid dithenyl ester was obtained as a pale yellow oil. Yield 77% MS m/e: 324 (M + ) IR ν neat nax cm -1 : 1750, 1185 (ester),
890
(Epoxy) NMR (CDCl 3 ) δ: 3.75 (2H, s,

【式】),5.41(4H,s,2×―O―CH2 ―),6.95〜7.85(6H,m,
[Formula]), 5.41 (4H, s, 2×-O-CH 2 -), 6.95-7.85 (6H, m,

【式】) 実施例 15 実施例13と同様にして、m―トリフルオロメチ
ルベンジルアルコール3.52gとエポキシコハク酸
ジクロリド1.68gより無色油状のエポキシコハク
酸ジ―m―トリフルオロメチルベンジルエステル
3.3gを得た。収率74% IR νneat naxcm-1:1755,1185(エステル)89
5
(エポキシ) NMR(CDCl3)δ:3.68(2H,s,
[Formula]) Example 15 Colorless oily epoxysuccinic acid di-m-trifluoromethylbenzyl ester was prepared from 3.52 g of m-trifluoromethylbenzyl alcohol and 1.68 g of epoxysuccinic acid dichloride in the same manner as in Example 13.
3.3g was obtained. Yield 74% IR ν neat nax cm -1 : 1755, 1185 (ester) 89
Five
(Epoxy) NMR (CDCl 3 ) δ: 3.68 (2H, s,

【式】),5.17(4H,s,2×―O―CH2 ―),7.43(8H,br s,
[Formula]), 5.17 (4H, s, 2×-O-CH 2 -), 7.43 (8H, br s,

【式】) 実施例 16 実施例13と同様にして、3,5―ジメチルベン
ジルアルコール2.72gとエポキシコハク酸ジクロ
リド1.68gより無色油状のエポキシコハク酸ジ―
3,5―ジメチルベンジルエステル2.9gを得
た。収率79% MS m/e:368(M+) IR νneat naxcm-1:1750,1185(エステル),
895
(エポキシ) MMR:δCDCl32.28(12H,s,4×―CH3),
3.66(2H,s,
[Formula]) Example 16 In the same manner as in Example 13, a colorless oily epoxysuccinic acid di-
2.9 g of 3,5-dimethylbenzyl ester was obtained. Yield 79% MS m/e: 368 (M + ) IR ν neat nax cm -1 : 1750, 1185 (ester),
895
(Epoxy) MMR: δ CDCl3 2.28 (12H, s, 4×-CH 3 ),
3.66(2H,s,

【式】),5.07(4H,s, 2×―O―CH2―),6.88(6H,s,
[Formula]), 5.07 (4H, s, 2×-O-CH 2 -), 6.88 (6H, s,

【式】) 実施例13と同様にして、該当するアルコール及
びエポキシコハク酸ジクロリドを原料として以下
に示すエポキシコハク酸ジエステルを得た。 エポキシコハク酸ジ―O―フルオロベンジルエ
ステル エポキシコハク酸ジ―O―メチルベンジルエス
テル エポキシコハク酸ジ―2,4,6―トリメチル
ベンジルエステル
[Formula]) In the same manner as in Example 13, the following epoxysuccinic acid diester was obtained using the corresponding alcohol and epoxysuccinic acid dichloride as raw materials. Epoxysuccinic acid di-O-fluorobenzyl ester Epoxysuccinic acid di-O-methylbenzyl ester Epoxysuccinic acid di-2,4,6-trimethylbenzyl ester

Claims (1)

【特許請求の範囲】 1 一般式 (式中、Rは「ハロゲン原子、メチル基、メト
キシ基及びトリフルオロメチル基」から選ばれる
1〜3個の置換基を有するベンジル基、ピペロニ
ル基、1―ナフチルメチル基、「ハロゲン原子お
よびメチル基」から選ばれる1〜2個の置換基を
有する1―ナフチルメチル基、3―フエニル―2
―プロペニル基、フルフリル基、2―テニル基ま
たはテトラヒドロフルフリル基を示す。)で表わ
されるエポキシコハク酸ジエステル化合物。
[Claims] 1. General formula (In the formula, R is a benzyl group having 1 to 3 substituents selected from "halogen atom, methyl group, methoxy group and trifluoromethyl group", piperonyl group, 1-naphthylmethyl group, "halogen atom and methyl 1-naphthylmethyl group, 3-phenyl-2 having 1 to 2 substituents selected from
- Indicates a propenyl group, furfuryl group, 2-thenyl group or tetrahydrofurfuryl group. ) An epoxysuccinic acid diester compound represented by
JP4683278A 1978-04-20 1978-04-20 Epoxysuccinic acid diester Granted JPS54141737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4683278A JPS54141737A (en) 1978-04-20 1978-04-20 Epoxysuccinic acid diester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4683278A JPS54141737A (en) 1978-04-20 1978-04-20 Epoxysuccinic acid diester

Publications (2)

Publication Number Publication Date
JPS54141737A JPS54141737A (en) 1979-11-05
JPS62909B2 true JPS62909B2 (en) 1987-01-10

Family

ID=12758297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4683278A Granted JPS54141737A (en) 1978-04-20 1978-04-20 Epoxysuccinic acid diester

Country Status (1)

Country Link
JP (1) JPS54141737A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108774A (en) * 1982-12-13 1984-06-23 Nippon Chemiphar Co Ltd Preparation of epoxysuccinic acid monoester

Also Published As

Publication number Publication date
JPS54141737A (en) 1979-11-05

Similar Documents

Publication Publication Date Title
TAMAI et al. Efficient synthetic method for ethyl (+)-(2S, 3S)-3-[(S)-3-methyl-1-(3-methylbutylcarbamoyl) butylcarbamoyl]-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases
JPS6333343A (en) Novel intermediate compound for manufacturing pyridyl compound
US4833164A (en) 2-substituted-1-naphthols, pharmaceutical compositions of, and their use as 5-lipoxygenase inhibitors
IE54220B1 (en) Phenol esters
US3957794A (en) 3-Amino-2,3,3a,6,7,7a-hexahydro-thieno[3,2-b]pyridin-(4H)5-one
JPS6334855B2 (en)
JPS62909B2 (en)
FR2609988A1 (en) NOVEL OXY-5 DERIVATIVES OF TETRAHYDROFURAN AND A PROCESS FOR THEIR PREPARATION
JPH032134B2 (en)
US4007217A (en) Process for producing 2-hydroxy-3-butenoic acid derivatives
EP0002408A1 (en) Substituted phenoxyalkanols, their preparation and their use as therapeutic agents
JPS62908B2 (en)
JPH04178359A (en) Tetracycline derivative
US4739059A (en) Fluorine-containing amine amides
CA2052892A1 (en) Inhibitors of hiv protease
JP3019528B2 (en) Process for producing β-lactone and macrocyclic ketone
US4985435A (en) 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
EP0323303B1 (en) Nicotinoyl piperazine derivatives, process for their preparation and their therapeutical use
JPH01211575A (en) Oxyimino derivative of thiazole and its production and use thereof in treatment
JPS6354333A (en) Optically active alcohol compound
JPS6377868A (en) Alpha-(omega-hydroxyalkyl)furfuryl alcohol and production thereof
US5026759A (en) 2-substituted-1-naphthols as 5-lipoxygenase inhibitors
JPS5883686A (en) Manufacture of aminocyclopentane alkenoic acid
Ross et al. Esterification and addition reactions of perfluoroacryloyl chloride
Smith et al. Structural requirements for phenylalanine antagonism